The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

Abstract Background An uninterrupted dose of oxaliplatin-based cytotoxic therapy is an essential component in the standard treatment regimen of metastatic colon cancer (mCC). Data on the impacts of dose intensity reduction on the palliative treatment for patients with mCC remain scarce. Hence, this...

Full description

Bibliographic Details
Main Authors:	Mohd Naqib Zainal Abidin, Marhanis Salihah Omar, Farida Islahudin, Noraida Mohamed Shah
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	BMC Cancer
Subjects:	Relative dose intensity Dose reduction Dose delays Dose modifications Metastatic colorectal Cancer Palliative chemotherapy
Online Access:	https://doi.org/10.1186/s12885-022-09831-7

Similar Items

Retrospective analysis of the impact of dose delay and reduction on outcomes of colorectal cancer patients treated with FOLFIRI‑based treatment
by: Xia Zhang, et al.
Published: (2023-09-01)

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
by: Stefan Munker, et al.
Published: (2018-04-01)

Assessment of Quality of Life in Recurrent and Metastatic Head and Neck Cancer after Oral Metronomic Chemotherapy: A Prospective Interventional Study
by: Vipul Nautiyal, et al.
Published: (2021-07-01)

Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
by: Xiaoqin Ji, et al.
Published: (2023-01-01)

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
by: Aboelnaga Engy M, et al.
Published: (2021-08-01)

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
by: Feng Wang, et al.
Published: (2019-05-01)

Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
by: Navin Nayan, et al.
Published: (2018-01-01)

The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective Analysis
by: Suganija Lakkunarajah, et al.
Published: (2021-10-01)

Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study
by: In Gyu Hwang, et al.
Published: (2021-01-01)

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice
by: Wayne J. Aston, et al.
Published: (2017-10-01)

Relative dose intensity of systemic chemotherapy in an outpatient cancer center
by: Christine Uptigrove, et al.
Published: (2010-11-01)

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
by: Jolanta Żok, et al.
Published: (2021-05-01)

Salvage Surgery for Metastatic Gall Bladder Cancer with Vanishing Liver Metastasis Following Palliative 5-Fluorouracil Metronomic Chemotherapy
by: RDR Somasekar, et al.
Published: (2017-05-01)

Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation
by: Daniel H. Miller, et al.
Published: (2015-10-01)

Can use of pictograms reduce liquid medication administration errors by mothers? An interventional study
by: Pawan Patidar, et al.
Published: (2021-06-01)

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
by: Sophie Kurk, et al.
Published: (2019-08-01)

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study
by: Kazuki Kobayashi, et al.
Published: (2022-09-01)

Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules
by: Mario Federico, et al.
Published: (2009-05-01)

The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients
by: Soohyeon Lee, et al.
Published: (2023-02-01)

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
by: Sabin Goktas Aydin, et al.
Published: (2023-11-01)

High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial
by: S S Babelyan, et al.
Published: (2014-03-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
by: John Benest, et al.
Published: (2020-03-01)

A Community Hospital-Based Study: A Prespecified Neutrophil Count with Adjuvant mFOLFOX6 Associated with Increased Delays, Increased G-CSF Use, and Reduced Dose Intensity
by: Chiarotto JA, et al.
Published: (2021-05-01)

Maintenance Chemotherapy for Patients with Rhabdomyosarcoma
by: Gianni Bisogno, et al.
Published: (2023-08-01)

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
by: Johannes Ettl, et al.
Published: (2020-03-01)

Evaluation of dosing strategy for pembrolizumab for oncology indications
by: Tomoko Freshwater, et al.
Published: (2017-05-01)

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
by: Daniel Breadner, et al.
Published: (2022-11-01)

Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia
by: Anirudh Sharma, et al.
Published: (2019-01-01)

Optimization and audit of radiation dose during percutaneous transluminal coronary angioplasty
by: Livingstone Roshan, et al.
Published: (2007-01-01)

A clinical comparison of high dose and low dose of Suxamethonium
by: RK Yadav, et al.
Published: (2014-01-01)

Verification of Response of Neutron Monitor for In-Flight Neutron Dosimetry
by: Claudio Antonio Federico, et al.
Published: (2013-08-01)

Radiation doses during chest examinations using dose modulation techniques in multislice CT scanner
by: Livingstone Roshan, et al.
Published: (2010-01-01)

Nitrogen and Potassium Fertilization in the Initial Growth of Annona crassiflora Mart.
by: Andréia Mendes da Costa, et al.
Published: (2019-04-01)

Radiation doses during chest examinations using dose modulation techniques in multislice CT scanner
by: Roshan S Livingstone, et al.
Published: (2010-04-01)

Methodology for Calculating Bacterial Endotoxin Limits
by: O. V. Shapovalova, et al.
Published: (2022-04-01)

EVALUATION OF PATIENT ABSORBED DOSE OF CONVENTIONAL X-RAYS USING DIRECT METHOD IN SOME HOSPITALS IN PORT HARCOURT, NIGERIA
by: Etim, et al.
Published: (2022-05-01)

Dosimetry in dentistry
by: M L Asha, et al.
Published: (2015-01-01)

Erratum: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts
by: Frontiers Production Office
Published: (2024-04-01)

Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts
by: Pamela Akuwudike, et al.
Published: (2023-12-01)

Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT)
by: Shujuan Zhou, et al.
Published: (2023-10-01)